Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

AstraZeneca - D419CR00035 - (Liver-R)

Study Phase: Observational - Registry

Condition(s): Liver or biliary tract cancer
An Observational Multi-center Study to Evaluate Real-World Treatment Outcomes of Durvalumab-based Regimens in Hepatobiliary Cancers

ClinicalTrials.gov NCT ID: NCT06252753

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_vivian-colon

Vivian Colon

Primary Contact - Study Coordinator

484-658-1793
vivian.colon@sluhn.org

proothi-subhash-profile

Subhash C. Proothi, MD

Physician - Principal Investigator

NRG-CC014

Study Phase: Phase III

Condition(s): Asymptomatic, high-risk bone metastases from any solid tumor, excluding multiple myeloma
NRG CC014: Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Mulitcenter Randomized Phase 3 Clinical Trial (PREEMPT)

ClinicalTrials.gov NCT ID: NCT06745024

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_amy-grossman

Amy Grossman, RN

Primary Contact - Study Coordinator

484-658-1788
amy.grossman@sluhn.org

profile_william-smith

William H. Smith, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today